Vista Capital Partners Inc. Takes $42,000 Position in Tilray Inc (NASDAQ:TLRY)

Vista Capital Partners Inc. purchased a new position in shares of Tilray Inc (NASDAQ:TLRY) during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 24,074 shares of the company’s stock, valued at approximately $42,000.

A number of other institutional investors and hedge funds have also recently bought and sold shares of TLRY. Bank of Montreal Can increased its position in shares of Tilray by 19.6% during the second quarter. Bank of Montreal Can now owns 2,169,100 shares of the company’s stock worth $3,622,000 after acquiring an additional 355,778 shares during the last quarter. Lazard Asset Management LLC acquired a new position in shares of Tilray in the 1st quarter valued at approximately $118,000. Avantax Advisory Services Inc. raised its position in shares of Tilray by 46.2% in the 1st quarter. Avantax Advisory Services Inc. now owns 53,110 shares of the company’s stock valued at $131,000 after purchasing an additional 16,792 shares in the last quarter. Concurrent Investment Advisors LLC acquired a new stake in shares of Tilray during the first quarter worth approximately $75,000. Finally, The Manufacturers Life Insurance Company increased its stake in shares of Tilray by 11.5% in the second quarter. The Manufacturers Life Insurance Company now owns 682,478 shares of the company’s stock worth $1,131,000 after buying an additional 70,605 shares during the last quarter. Hedge funds and other institutional investors own 9.35% of the company’s stock.

Wall Street Analyst Weigh In

Separately, Roth Mkm reduced their price objective on shares of Tilray from $2.00 to $1.75 and set a “neutral” rating on the stock in a research note on Friday, October 11th.

Tilray Trading Up 0.6 %

NASDAQ:TLRY opened at $1.55 on Friday. The business’s 50 day moving average is $1.68 and its two-hundred day moving average is $1.79. The company has a quick ratio of 1.57, a current ratio of 2.47 and a debt-to-equity ratio of 0.08. Tilray Inc has a 52 week low of $1.45 and a 52 week high of $2.97.

Tilray (NASDAQ:TLRY) last announced its quarterly earnings data on Thursday, October 10th. The company reported ($0.04) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.04). The firm had revenue of $200.00 million for the quarter, compared to analysts’ expectations of $218.70 million. Tilray had a negative return on equity of 2.00% and a negative net margin of 26.79%. The firm’s revenue for the quarter was up 13.0% on a year-over-year basis. During the same period last year, the business posted ($0.10) earnings per share. On average, research analysts predict that Tilray Inc will post -0.14 earnings per share for the current fiscal year.

Tilray Profile

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.